Enhancement of chemotherapeutic drug toxicity to human tumour cells in vitro by a subset of non-steroidal anti-inflammatory drugs (NSAIDs)
- 1 July 1998
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 34 (8) , 1250-1259
- https://doi.org/10.1016/s0959-8049(98)00045-8
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- RETRACTED: ATP-dependent uptake of natural product cytotoxic drugs by membrane vesicles establishes MRP as a broad specificity transporter.Proceedings of the National Academy of Sciences, 1996
- Pharmacological considerations in the modulation of multidrug resistanceEuropean Journal Of Cancer, 1996
- Biology of the multidrug resistance-associated protein, MRPEuropean Journal Of Cancer, 1996
- Expression Pattern of MRP in Human Tissues and Adult Solid Tumor Cell LinesJNCI Journal of the National Cancer Institute, 1995
- The Leukotriene LTD4 Receptor Antagonist Mk571 Specifically Modulates MRP Associated Multidrug ResistanceBiochemical and Biophysical Research Communications, 1995
- The Specific Bisindolylmaleimide PKC-Inhibitor GF 109203X Efficiently Modulates MRP-Associated Multiple Drug ResistanceBiochemical and Biophysical Research Communications, 1995
- Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport.Proceedings of the National Academy of Sciences, 1994
- Competitive inhibition by genistein and ATP dependence of daunorubicin transport in intact MRP overexpressing human small cell lung cancer cellsBiochemical Pharmacology, 1994
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell LineScience, 1992